103 related articles for article (PubMed ID: 11694304)
1. Discriminative disulfide-bonding affinity labeling of opioid receptor subtypes.
Shirasu N; Shimohigashi Y
J Biochem Biophys Methods; 2001 Oct; 49(1-3):587-606. PubMed ID: 11694304
[TBL] [Abstract][Full Text] [Related]
2. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs.
Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y
J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834
[TBL] [Abstract][Full Text] [Related]
3. Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs.
Shirasu N; Kuromizu T; Nakao H; Chuman Y; Nose T; Costa T; Shimohigashi Y
J Biochem; 1999 Jul; 126(1):254-9. PubMed ID: 10393346
[TBL] [Abstract][Full Text] [Related]
4. Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptor.
Matsushima A; Nishimura H; Inamine S; Uemura S; Shimohigashi Y
Bioorg Med Chem; 2011 Dec; 19(24):7597-602. PubMed ID: 22061823
[TBL] [Abstract][Full Text] [Related]
5. Discriminative affinity labelling of opioid receptors by enkephalin and morphiceptin analogues containing 3-nitro-2-pyridinesulphenyl-activated thiol residues.
Shimohigashi Y; Takada K; Sakamoto H; Matsumoto H; Yasunaga T; Kondo M; Ohno M
J Chromatogr; 1992 Apr; 597(1-2):425-8. PubMed ID: 1325466
[TBL] [Abstract][Full Text] [Related]
6. 14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding properties.
Archer S; Seyed-Mozaffari A; Jiang Q; Bidlack JM
J Med Chem; 1994 May; 37(11):1578-85. PubMed ID: 7515442
[TBL] [Abstract][Full Text] [Related]
7. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
8. Specific affinity-labeling of the nociceptin ORL1 receptor using a thiol-activated Cys(Npys)-containing peptide ligand.
Matsushima A; Nishimura H; Matsuyama Y; Liu X; Costa T; Shimohigashi Y
Biopolymers; 2016 Nov; 106(4):460-9. PubMed ID: 27271345
[TBL] [Abstract][Full Text] [Related]
9. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
10. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
[TBL] [Abstract][Full Text] [Related]
11. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
Gaibelet G; Capeyrou R; Dietrich G; Emorine LJ
FEBS Lett; 1997 May; 408(2):135-40. PubMed ID: 9187354
[TBL] [Abstract][Full Text] [Related]
12. Preparation of Boc-[S-(3-nitro-2-pyridinesulfenyl)]-cysteine and its use for unsymmetrical disulfide bond formation.
Bernatowicz MS; Matsueda R; Matsueda GR
Int J Pept Protein Res; 1986 Aug; 28(2):107-12. PubMed ID: 3771096
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation.
Gioannini TL; Liu YF; Park YH; Hiller JM; Simon EJ
J Mol Recognit; 1989 Jul; 2(1):44-8. PubMed ID: 2561526
[TBL] [Abstract][Full Text] [Related]
14. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.
Bidlack JM; Frey DK; Kaplan RA; Seyed-Mozaffari A; Archer S
Mol Pharmacol; 1990 Jan; 37(1):50-9. PubMed ID: 1688995
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
16. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
Minami M; Onogi T; Nakagawa T; Katao Y; Aoki Y; Katsumata S; Satoh M
FEBS Lett; 1995 May; 364(1):23-7. PubMed ID: 7750536
[TBL] [Abstract][Full Text] [Related]
17. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406
[TBL] [Abstract][Full Text] [Related]
18. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB
Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells.
Chiang N; Kan WM; Tai HH
Arch Biochem Biophys; 1996 Oct; 334(1):9-17. PubMed ID: 8837733
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
